Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Medtronic Enterra II Neurostimulator

NCT06215547 is registered in ClinicalTrials.gov with Methodist Health System as lead sponsor.

NCT NCT06215547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06215547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Medtronic Enterra II Neurostimulator
Lead sponsor
Methodist Health System
Phase
Not applicable
Overall status
Unknown status
Start date
September 15, 2015
Completion date
September 14, 2025
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastroparesis